ArdorComm Media Group

Friday, June 19, 2026 12:15 PM

News

Novartis India Launches Pluvicto, Bringing Advanced Precision Therapy for Prostate Cancer Patients

ArdorComm Media News Network

Novartis India has announced the launch of Pluvicto, India’s first regulatory-approved radioligand therapy designed for eligible patients suffering from PSMA-positive metastatic prostate cancer, marking a significant advancement in precision oncology treatment in the country. The newly introduced therapy, Pluvicto (lutetium-177Lu